IDEXX LABORATORIES INC /DE (IDXX) Operating cash flow 2016–2025
IDEXX LABORATORIES INC /DE (IDXX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.2BFY2025 · since FY2016: $338.9M → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +27.2% |
| FY2024 | $929.0M | +2.5% |
| FY2023 | $906.5M | +66.9% |
| FY2022 | $543.0M | -28.1% |
| FY2021 | $755.5M | +16.6% |
| FY2020 | $648.1M | +41.1% |
| FY2019 | $459.2M | +14.8% |
| FY2018 | $400.1M | +7.2% |
| FY2017 | $373.3M | +10.1% |
| FY2016 | $338.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXX financial trends
IDXX RevenueIDXX Net incomeIDXX Net marginIDXX Gross profitIDXX Gross marginIDXX Operating incomeIDXX Operating marginIDXX Free cash flowIDXX Capital expendituresIDXX Return on equityIDXX Stock buybacksIDXX Dividends paidIDXX Total assetsIDXX Total liabilitiesIDXX Shareholders’ equityIDXX overview →